Trial Profile
The Effect of Linagliptin on Mitochondrial and Endothelial Function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Nov 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 01 Sep 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 01 Sep 2016 Primary endpoint has not been met. (Phosphocreatine (PCR) recovery time after exhaustive or up to 6 minutes of leg exercise.), as reported in an article published in the Journal of Clinical Endocrinology and Metabolism.